BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 126 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532 | +3.9% | 73,765 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $512 | -13.8% | 73,765 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $594 | -26.8% | 73,765 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $811 | -99.9% | 73,765 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $895,000 | +14.6% | 73,765 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $781,000 | -35.6% | 73,765 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $1,213,000 | +35.7% | 73,765 | +10.0% | 0.00% | +50.0% |
| Q4 2021 | $894,000 | -3.2% | 67,065 | +2.8% | 0.00% | -33.3% |
| Q3 2021 | $924,000 | -7.1% | 65,265 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $995,000 | +54.7% | 65,265 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $643,000 | -12.4% | 65,265 | -38.0% | 0.00% | -33.3% |
| Q4 2020 | $734,000 | +3.2% | 105,265 | -41.6% | 0.00% | 0.0% |
| Q3 2020 | $711,000 | +611.0% | 180,265 | +472.3% | 0.00% | +200.0% |
| Q3 2019 | $100,000 | -56.3% | 31,500 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $229,000 | -17.0% | 63,000 | +63.6% | 0.00% | -50.0% |
| Q1 2019 | $276,000 | +10.0% | 38,500 | +22.2% | 0.00% | 0.0% |
| Q4 2018 | $251,000 | -9.1% | 31,500 | -18.2% | 0.00% | 0.0% |
| Q3 2018 | $276,000 | +20.5% | 38,500 | -2.5% | 0.00% | +100.0% |
| Q2 2018 | $229,000 | +21.2% | 39,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $189,000 | +96.9% | 39,500 | +12.9% | 0.00% | 0.0% |
| Q1 2016 | $96,000 | -75.3% | 35,000 | -5.4% | 0.00% | -75.0% |
| Q4 2015 | $388,000 | -6.7% | 37,000 | +1.4% | 0.00% | -20.0% |
| Q3 2015 | $416,000 | -20.5% | 36,500 | +4.3% | 0.01% | -16.7% |
| Q2 2015 | $523,000 | +72.0% | 35,000 | +3.9% | 0.01% | +50.0% |
| Q1 2015 | $304,000 | -34.9% | 33,700 | -12.7% | 0.00% | -33.3% |
| Q4 2014 | $467,000 | +13.3% | 38,600 | -8.3% | 0.01% | 0.0% |
| Q3 2014 | $412,000 | -19.2% | 42,100 | +5.2% | 0.01% | -25.0% |
| Q2 2014 | $510,000 | +32.1% | 40,000 | +9.6% | 0.01% | +33.3% |
| Q1 2014 | $386,000 | – | 36,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |